Washington: Convalescent plasma therapy is “futile” as a treatment for most critically ill COVID-19 patients, according to a study published on Tuesday. The findings, published in the journal JAMA, are the latest from the REMAP-CAP trial, which has enrolled thousands of patients in hundreds of hospitals globally to quickly determine what COVID-19 treatments work best in […]
